Last year, our Research and Development team was called on by the U.S. Centers for Disease Control and Prevention (CDC) to develop a more effective screen for hepatitis C, a chronic blood-borne infection that was going undetected in large numbers of “baby boomers.” Swift action led to a one-time test now covered by Medicare and Medicaid that will help protect 3.2 million Americans against outcomes like liver damage, cirrhosis, liver cancer and even death.